Company Q-linea AB

Equities

QLINEA

SE0011527845

Advanced Medical Equipment & Technology

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

Ratings for Q-linea AB

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Medical Diagnostic & Testing Equipment

Delayed Nasdaq Stockholm Other stock markets 11:59:43 30/04/2024 BST			5-day change	1st Jan Change
2.595 ^SEK	-10.82%		+24.76%	-29.86%

03-13	Q-linea AB Presents Strong ASTar Results At AMCLI	CI
02-27	Transcript : Q-linea AB, Q4 2023 Earnings Call, Feb 27, 2024

Q linea AB is a Sweden-based medical technology company. The Company develops and manufactures in-vitro diagnostic (IVD) solutions for infectious diseases. The Company's core product candidate is ASTar, a fully-automated instrument for Antibiotic Susceptibility Testing (AST). It measures bacteria's antimicrobial susceptibility using the disposables developed by the Company. It is able to provide a susceptibility profile within three to six hours directly from a positive blood culture, which enables early administration of antibiotics specifically targeting the disease-causing pathogen. Its main application is the identification of sepsis in hospital patients and the product is aimed primarily at hospital laboratories.

Number of employees: 127

SEK in Million	2022	Weight	2023	Weight	Delta
Instruments and Consumables 100.0 %	13	100.0 %	4	100.0 %	-65.28%

SEK in Million	2022	Weight	2023	Weight	Delta
European Union 64.3 %	-	-	3	64.3 %	-
United Kingdom 34.3 %	13	100.0 %	2	34.3 %	-88.10%
Sweden 1.4 %	0	0.0 %	0	1.4 %	-

Managers	Title	Age	Since
Jonas Sven Peter Jarvius FOU	Founder	53	31/03/08
Christer Lennart Samuelsson DFI	Director of Finance/CFO	70	30/04/23
Henrik Jacobsson COO	Chief Operating Officer	55	31/12/21
Tiziana di Martino CTO	Chief Tech/Sci/R&D Officer	48	11/07/19
Mats Gullberg CTO	Chief Tech/Sci/R&D Officer	53	-
Jim Kathrein PRN	Corporate Officer/Principal	-	05/07/23
Thomas Fritz PRN	Corporate Officer/Principal	60	02/09/19
Ulrika Stolpe HRO	Human Resources Officer	57	31/12/11

Members of the board	Title	Age	Since
Erika Kjellberg-Eriksson CHM	Chairman	62	31/12/11
Mats Bo Johan Nilsson Bernitz FOU	Founder	54	31/03/08
Hans Olof Gunnar Johansson BRD	Director/Board Member	70	31/12/17
Finn Albrechtsen BRD	Director/Board Member	57	12/06/23
Karin Fischer BRD	Director/Board Member	48	12/06/23
Mario Gualano BRD	Director/Board Member	55	25/05/20
Nina Korfu-Pedersen BRD	Director/Board Member	51	23/05/22

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	117,494,844	109,981,576 ( 93.61 %)	328,472 ( 0.2796 %)	93.61 %

Name	Equities	%	Valuation
Aktie-Ansvar AB 1.041 %	1,220,000	1.041 %	244 171 kr
Pareto Asset Management AS 0.0666 %	78,000	0.0666 %	15 611 kr
Anders Lundin 0.0234 %	27,363	0.0234 %	5 476 kr
Mats Gullberg 0.0189 %	22,088	0.0189 %	4 421 kr
Storebrand Asset Management AS 0.0183 %	21,463	0.0183 %	4 296 kr
Case Kapitalförvaltning AB 0.003055 %	3,580	0.003055 %	717 kr
Danske Bank A/S (Investment Management) 0.000282 %	330	0.000282 %	66 kr

Q-linea AB

Dag Hammarskjölds Väg 52 A

752 37, Uppsala

+46 1 84 44 36 10

http://www.qlinea.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
Q-LINEA AB	-29.86%	27.6M
SARTORIUS AG	-15.28%	18.56B
QUIDELORTHO CORPORATION	-44.98%	2.71B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+17.00%	1.85B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-0.51%	1.66B
BIOTAGE AB	+25.65%	1.22B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-13.90%	989M
CONTEC MEDICAL SYSTEMS CO.,LTD	-21.76%	896M
REVENIO GROUP OYJ	-3.53%	745M
VAREX IMAGING CORPORATION	-20.73%	660M

Medical Diagnostic & Testing Equipment